Benitec Biopharma (BNTC) Short Interest Ratio & Short Volume → Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (From Small Cap Sniper) (Ad) Free BNTC Stock Alerts $8.22 +0.10 (+1.23%) (As of 01:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Benitec Biopharma Short Interest DataCurrent Short Volume98,500 sharesPrevious Short Volume12,200 sharesChange Vs. Previous Month+707.38%Dollar Volume Sold Short$832,325.00Short Interest Ratio / Days to Cover1.2Last Record DateApril 30, 2024Outstanding Shares2,590,000 sharesFloat Size1,570,000 sharesShort Percent of Float6.27%Today's Trading Volume14,961 sharesAverage Trading Volume63,552 sharesToday's Volume Vs. Average24% Short Selling Benitec Biopharma ? Sign up to receive the latest short interest report for Benitec Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBNTC Short Interest Over TimeBNTC Days to Cover Over TimeBNTC Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe World’s Richest Man Blindsided by AIThese billionaires know that early investors in AI stand to make a lot of money. The same is true for everyday Americans... including you.Get the full story here. Benitec Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202498,500 shares $832,325.00 +707.4%6.3%1.2 $8.45 4/15/202412,200 shares $59,902.00 +10.9%0.5%0.2 $4.91 3/31/202411,000 shares $57,750.00 +115.7%0.5%0.7 $5.25 3/15/20245,100 shares $26,010.00 -68.3%0.2%0.4 $5.10 2/29/202416,100 shares $78,085.00 +151.6%0.7%1.1 $4.85 2/15/20246,400 shares $18,432.00 -18.0%0.3%0.5 $2.88 Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,800 shares $21,918.00 +25.8%0.3%0.9 $2.81 1/15/20246,200 shares $18,166.00 -18.4%0.3%0.7 $2.93 12/31/20237,600 shares $24,548.00 -39.7%0.3%0.7 $3.23 12/15/202312,600 shares $42,462.00 +5.9%0.6%1.1 $3.37 11/30/202311,900 shares $37,842.00 -64.4%0.5%0.8 $3.18 11/15/202333,400 shares $125,918.00 -28.2%1.5%1.6 $3.77 10/31/202346,500 shares $167,865.00 -20.7%3.1%0.6 $3.61 10/15/202358,600 shares $199,826.00 -13.7%3.9%0.1 $3.41 9/30/202367,900 shares $205,173.43 -24.7%4.6%0.1 $3.02 9/15/202390,200 shares $285,032.00 -33.8%6.1%0.1 $3.16 8/31/2023136,300 shares $402,085.00 -51.1%9.2%0.2 $2.95 8/15/2023278,500 shares $749,165.00 +52.2%N/A0.4 $2.69 7/31/2023183,000 shares $563,640.00 -81.2%N/A0.3 $3.08 7/15/2023974,300 shares $223,991.57 -57.3%N/A0.3 $0.23 6/30/20232,280,000 shares $543,780.00 +1,061.5%N/A0.7 $0.24 6/15/2023196,300 shares $46,110.87 -22.8%N/A0.1 $0.23 5/31/2023254,300 shares $61,311.73 -19.9%N/A0.9 $0.24 5/15/2023317,400 shares $67,856.95 -5.8%N/A1.1 $0.21 4/30/2023337,000 shares $67,770.70 +77.9%N/A1 $0.20 4/15/2023189,400 shares $40,436.71 +73.4%N/A0.6 $0.21 3/31/2023109,200 shares $22,921.08 -45.0%N/A0.4 $0.21 3/15/2023198,700 shares $46,694.50 -52.5%N/A0.6 $0.24 2/28/2023418,700 shares $125,610.00 +101.1%N/A0.9 $0.30 2/15/2023208,200 shares $47,760.87 -3.6%N/A0.5 $0.23 1/31/2023215,900 shares $49,657.00 -1.7%N/A0.5 $0.23 1/15/2023219,600 shares $50,925.24 +109.9%N/A0.4 $0.23 12/30/2022104,600 shares $17,782.00 +245.2%N/A0.2 $0.17 12/15/202230,300 shares $4,545.00 -85.3%N/A0.1 $0.15 11/30/2022206,400 shares $42,312.00 +24.9%N/A0.3 $0.21 11/15/2022165,200 shares $28,596.12 -50.6%N/A0.3 $0.17 10/31/2022334,500 shares $58,637.85 +310.4%4.5%0.6 $0.18 10/15/202281,500 shares $19,486.65 -35.1%1.1%0.2 $0.24 9/30/2022125,600 shares $46,685.52 +187.4%2.1%0.4 $0.37 9/15/202243,700 shares $18,747.30 -87.7%0.6%0 $0.43Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… BNTC Short Interest - Frequently Asked Questions What is Benitec Biopharma's current short interest? Short interest is the volume of Benitec Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 98,500 shares of BNTC short. 6.27% of Benitec Biopharma's shares are currently sold short. Learn More on Benitec Biopharma's current short interest. What is a good short interest ratio for Benitec Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTC shares currently have a short interest ratio of 1.0. Learn More on Benitec Biopharma's short interest ratio. Which institutional investors are shorting Benitec Biopharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Benitec Biopharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Benitec Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.27% of Benitec Biopharma's floating shares are currently sold short. Is Benitec Biopharma's short interest increasing or decreasing? Benitec Biopharma saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 98,500 shares, an increase of 707.4% from the previous total of 12,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Benitec Biopharma's float size? Benitec Biopharma currently has issued a total of 2,590,000 shares. Some of Benitec Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Benitec Biopharma currently has a public float of 1,570,000 shares. How does Benitec Biopharma's short interest compare to its competitors? 6.27% of Benitec Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Benitec Biopharma: Sol-Gel Technologies Ltd. (0.04%), MEI Pharma, Inc. (0.37%), Synlogic, Inc. (0.36%), Alaunos Therapeutics, Inc. (9.57%), RenovoRx, Inc. (0.19%), Cumberland Pharmaceuticals Inc. (0.23%), CytoMed Therapeutics Limited (1.08%), Bullfrog AI Holdings, Inc. (3.62%), GlycoMimetics, Inc. (9.45%), TherapeuticsMD, Inc. (0.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Benitec Biopharma stock? Short selling BNTC is an investing strategy that aims to generate trading profit from Benitec Biopharma as its price is falling. BNTC shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Benitec Biopharma? A short squeeze for Benitec Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTC, which in turn drives the price of the stock up even further. How often is Benitec Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: SLGL Short Interest Data MEIP Short Interest Data SYBX Short Interest Data TCRT Short Interest Data RNXT Short Interest Data CPIX Short Interest Data GDTC Short Interest Data BFRG Short Interest Data GLYC Short Interest Data TXMD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNTC) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace